Fig. 8

ROC curves of dual-phase HU40 –100keV and SP40–100 for differentiation between non-moderate-to-severe CD group and moderate-to-severe activity group. (a) Arterial phase parameters of the diseased intestinal wall; (b) Portal phase parameters of the diseased intestinal wall; (c) Arterial phase parameters of creeping fat; (d) Portal phase parameters of creeping fat.